France: A leader in clinical trials
Clinical trials are a vital element of the pharmaceutical industry,
in which France is considered the best in Europe. Its expertise is
derived from several decades of collaboration with hospitals and
partners involved with French health sector..
CJ: The French Technology Press Office, Ubifrance, New Delhi,
India , 1 day ago Views:183 Comments:0
GLOBAL REVENUES of medical and pharmaceutical research are increasing
at the rate of 20 per cent , reaching a market size of US$ 15.4
billion in 2006. Companies look at France as the centre of excellence
for medical and pharmaceutical research, since the performance of
clinical trials in specialist hospitals is a key stage in the
treatment process.
Swiss pharmaceutical laboratory Novartis, for example, employs nearly
2,700 people in France, of which over 200 are dedicated to
international clinical trial programmes. Expertise in this field is
derived from several decades of collaboration with hospitals and the
various partners involved with the French health sector.
Alongside prestigious French contract research organisations are the
leading global clinical trial companies like Covance, Parexel, MDS
Pharma, and the US company Quintiles. The US company is the number
one in the industry and employs 600 people in France in two
locations - Paris and Strasbourg.
The quality of the clinical trials is what attracted biotechnology
company Myosix, a subsidiary of the US company Genzyme, which has
developed a particularly innovative technique for the growth of adult
muscle stem cells.
The creation of CeNGEPS - the national centre for managing clinical
trials, in Lyon, will play a key role in facilitating the
administrative organisation of clinical trials in the industry. The
government supports eight competitiveness clusters dedicated to life
sciences, which bring the various players together to work in a
climate of innovation. In addition, the pharmaceutical industry
benefits from the best research and development (R&D) tax credit
system in Europe, which reimburses 50 per cent of R&D costs in the
first year.
Clinical trials, a high value-added sector that is crucial for the
pharmaceutical industry, require cooperation between industry,
research laboratories, medical practitioners and service providers.
The efficient environment and high-quality technical facilities
created by France are assets for pharmaceutical companies that expect
successful results.
According to Philippe Favre, president of 'Invest in France Agency',
The French pharmaceutical market is the biggest in Europe and the
third-largest in the world. Its attractiveness is linked to the
quality of Frances healthcare system, recognised as one of the best
in the world by the World Health Organisation and the French hospital
system, which is number one in Europe.
Invest in France Agency (IFA) promotes and facilitates international
investment in France. The IFA network operates worldwide. It works in
partnership with regional development agencies to offer business
opportunities and customised services to international investors all
over France.
http://www.merinews
«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»«¤»¥«¤»§«¤»¥«¤»§«¤»¥«
¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
StemCells subscribers may also be interested in these sites:
Children's Neurobiological Solutions
http://www.CNSfoundation.org/
Cord Blood Registry
http://www.CordBlood.com/at.cgi?a=150123
The CNS Healing Group
http://groups.yahoo.com/group/CNS_Healing
____________________________________________
«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»«¤»¥«¤»§«¤»¥«¤»§«¤»¥«
¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
Change settings via the Web (Yahoo! ID required)
Change settings via email: Switch delivery to Daily Digest | Switch format to Traditional
Visit Your Group | Yahoo! Groups Terms of Use | Unsubscribe
__,_._,___
No comments:
Post a Comment